Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Analysis of Total Busulfan Exposure for Once Daily Intravenous Dosing in Paediatric Haematopoietic Stem Cell Transplantation- An ANZCHOG Pilot Study
Protocol ID
Bu4Day-PK-2016
Disease (Sub Disease)
Haematopoietic Stem Cell Transplant
Diagnosis Stage
Newly diagnosed
Relapsed/refractory
Location
NSW, QLD, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
Queensland Health- SERTA Grant
University of Queensland
Trial Status
Open
Sites
Perth Children's Hospital
Sydney Children's hospital
Queensland Children's Hospital
Study Type
Observational
Phase
Pilot
Age Eligibility
up to 18 years
ANZCTR
ACTRN12617000227392
Back to Registry
Study Title Analysis of Total Busulfan Exposure for Once Daily Intravenous Dosing in Paediatric Haematopoietic Stem Cell Transplantation- An ANZCHOG Pilot Study
Protocol ID Bu4Day-PK-2016
Disease (Sub Disease) Haematopoietic Stem Cell Transplant
Diagnosis Stage Newly diagnosed
Relapsed/refractory
Location NSW / QLD / WA
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Collaborators Queensland Health- SERTA Grant/ University of Queensland
Links https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372251&isReview=true
Trial Status Open
Trial Open Date 29/05/2017
Sites Perth Children's Hospital / Sydney Children's hospital / Queensland Children's Hospital
Study Type Observational
Phase Pilot
Age Eligibility up to 18 years
ANZCTR ACTRN12617000227392